Non-coding RNAs in Cardiovascular Diseases (Advances in Experimental Medicine and Biology, 1229) 1st ed. 2020 Edition

ISBN 10: 9811516731 / ISBN 13: 9789811516733

Edité par Springer, 2021

A propos de cet article

N° de réf. du vendeur 26384678380

Détails bibliographiques

• Titre: Non-coding RNAs in Cardiovascular Diseases (Advances in Experimental Medicine and Biology, 1229) 1st ed. 2020 Edition
• Éditeur: Springer
• Date de parution: 2021
• Langue: anglais
• ISBN à 10 chiffres: 9811516731
• ISBN à 13 chiffres: 9789811516733
• Reliure: Couverture souple
• État de l'article: New

A propos de ce titre

Synopsis

This book presents the latest research on non-coding RNAs in cardiovascular disease, a major cause of death worldwide. Non-coding RNAs play a significant role in development, proliferation, differentiation and apoptosis. Since altered non-coding RNA expression is often associated with various diseases, their potential use in diagnostics, prognostics and therapeutics is an important current area of study. The book consists of six parts: 1) An overview of non-coding RNAs and cardiovascular system, 2) Bioinformatics and interactions, 3) Non-coding RNA regulation in cardiovascular system, 4) Non-coding RNAs and cardiovascular diseases, 5) Potential biomarkers and therapeutic implications, 6) Future prospects. It is particularly useful for researchers and students in the field of non-coding RNA and cardiovascular biology, as well as for cardiologists, pharmacologists and physiologists.

À propos de l?auteur

Dr. Junjie Xiao is the Vice Dean of the School of Life Science and also of the Medical School (in preparation) at Shanghai University. He is the Associate Editor of the Journal of Cardiovascular Translational Research, BMC Sports and Science, Medicine& Rehabilitation, and a member of the editorial board of BMC Medicine. He is the author or co-author of numerous scientific articles in various journals, including Cell Metabolism, Nature Communications, Annual Review of Genomics and Human Genetics, Circulation, and Theranostics. His major research interest is exercise and myocardial protection, especially using exercise as a platform to identify novel targets for enhancing cardiac regeneration and combating heart failure.